1. Sentinel node biopsy and selective lymph node clearance—impact on regional control and survival in breast cancer and melanoma

   • Omgo E. Nieweg
   • Maartje C. van Rijk
   • Cornelis A. Hoefnagel

   Editorial 05 May 2005 Pages: 631 - 634

2. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study

   • Isabelle Brenot-Rossi
   • Cyril Bastide
   • Dominique Rossi

   Original Article 04 March 2005 Pages: 635 - 640

   

3. Occult lung infarction may induce false interpretation of ¹⁸F-FDG PET in primary staging of pulmonary malignancies

   • Ehab M. Kamel
   • Thomas A. Mckee
   • Angelika Bischof Delaloye

   Original Article 22 February 2005 Pages: 641 - 646

   

4. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?

   • Yu-Chen Chang
   • Tzu-Chen Yen
   • Hung-Hsueh Chou

   Original Article 10 February 2005 Pages: 647 - 652

5. [¹⁸F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors

   • Seung Jin Choi
   • Jae Seung Kim
   • Dae Hyuk Moon

   Original Article 15 February 2005 Pages: 653 - 659

   

6. [methyl-³H]Choline incorporation into MCF7 tumour cells: correlation with proliferation

   • Fatma Al-Saeedi
   • Andy E. Welch
   • Tim A. D. Smith

   Original Article 20 January 2005 Pages: 660 - 667

   

7. In vivo uptake of [¹¹C]choline does not correlate with cell proliferation in human prostate cancer

   • Anthonius J. Breeuwsma
   • Jan Pruim
   • Igle J. de Jong

   Original Article 12 March 2005 Pages: 668 - 673

   

8. The value of [¹⁸F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease

   • Martin A. Walter
   • Ralph A. Melzer
   • Egbert U. Nitzsche

   Original Article 04 March 2005 Pages: 674 - 681

   

9. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy

   • Cecilia Marini
   • Assuero Giorgetti
   • Gianmario Sambuceti

   Original Article 04 March 2005 Pages: 682 - 688

   

10. Early-stage [¹²³I]β-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease

    • Diederick Stoffers
    • Jan Booij
    • Henk W. Berendse

    Original Article 29 January 2005 Pages: 689 - 695

    

11. Voxel-based statistical analysis of cerebral glucose metabolism in the rat cortical deafness model by 3D reconstruction of brain from autoradiographic images

    • Jae Sung Lee
    • Soon-Hyun Ahn
    • Myung Chul Lee

    Original Article 04 March 2005 Pages: 696 - 701

    

12. ^99mTc-sestamibi thyroid uptake in euthyroid individuals and in patients with autoimmune thyroid disease

    • Allan O. Santos
    • D.E. Zantut-Wittmann
    • C.D. Ramos

    Original Article 10 February 2005 Pages: 702 - 707

    

13. The effect of citalopram hydrobromide on 5-HT_2A receptors in the impulsive–aggressive dog, as measured with ¹²³I-5-I-R91150 SPECT

    • K. Peremans
    • K. Audenaert
    • R. Dierckx

    Molecular Imaging 01 March 2005 Pages: 708 - 716

    

14. Molecular imaging of individual behaviour

    • R. M. Moresco
    • F. Fazio

    Editorial Commentary 30 April 2005 Pages: 717 - 719

15. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy

    • D. Wydra
    • S. Sawicki
    • T. Bandurski

    Letter to the Editor 10 March 2005 Pages: 720 - 721

16. Reply

    • Rik Pijpers

    Letter to the Editor 10 March 2005 Pages: 722 - 722

17. Sequential FDG PET/CT in ⁹⁰Y microsphere treatment of unresectable colorectal liver metastases

    • Maren Bienert
    • Barry McCook
    • Norbert Avril

    Image of the Month 14 December 2004 Pages: 723 - 723

    

18. ⁶⁸Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5

    • Damian Wild
    • Helmut R. Mäcke
    • Michael Hofmann

    Image of the Month 18 November 2004 Pages: 724 - 724